PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

Chronic coronary syndromes can more than triple a person's chances of developing diabetes, researchers found. 

The global trial is designed to compare TAVR systems from Medtronic and Edwards Lifesciences when treating patients with small annuli.

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far.